Puregon® (ORG 32489) - Recombinant human follicle-stimulating hormone

Drugs of Today

Volumn 32, Issue 3, 1996, Pages 239-258

  Geurts, T B P ^a   Peters, M J H ^a   Van Bruggen, J G C ^a   De Boer, W ^a   Out, H J ^a  

^a NV ORGANON   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUSERELIN; CHORIONIC GONADOTROPIN; GONADORELIN AGONIST; RECOMBINANT FOLLITROPIN; TRIPTORELIN; UROFOLLITROPIN;

BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; OVARY HYPERSTIMULATION; REVIEW; SPECIES DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029897233     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.1996.32.3.343088     Document Type: Review

References (49)

1. Healy, D.L., Trounson, A.O., Andersen, A.N. Female infertility: Causes and treatment. Lancet 1994, 343: 1539-44.
2. van Wezenbeek, P. Draaijer, J., van Meel, F., Olijve, W. Recombinant follicle-stimulating hormone. I Construction, selection and characterization of a cell line. In: From Clone to Clinic. Crommelin, D.J.A., Schellekens, H. (Eds.). Kluwer Academic Publishers: Dordrecht 1990, 245-51.
3. Chin, W.W. In: Molecular Cloning of Hormone Genes. Habener, J.F. (Ed.). Humana Press Inc. 1987, 1320-72.
4. Fiddes, J.C., Goodman, H.M.J. The gene encoding the common alpha subunit of the four glycoprotein hormones. Mol Appl Genet 1981, 1: 3-18.
5. Pierce, J.G., Parsons, T.F. Glycoprotein hormones: Structure and function. Ann Rev Biochem 1982, 50: 465-95.
6. Sairam, M.R. Gonadotrophic hormones: Relationship between structure and function with emphasis on antagonists. In: Hormonal Proteins and Peptides, Vol. 11. Li, C.H. (Ed.). Academic Press: New York 1983, 1-79.
7. Ryan, R.J., Keutmann, H.T., Charlesworth, M.C. et al. Structure-function relationships of gonadotropins. Rec Prog Horm Res 1987, 43: 383-429.
8. Talmadge, K., Boorstein, W.R., Fiddes. J.C. The human genome contains seven genes for the β-subunit of chorionicgonadotropin but only one gene for the β-subunit of luteinizing hormone DNA. 1982, 2: 279-87.
9. Kornfield, R., Kornfield, S. Assembly of asparagine-linked oligosaccharides. Ann Rev Biochem 1985, 54: 631-4.
10. Hirschberg, C.B., Snider, M.D. Topography of glycosylation in the rough endoplasmic reticulum and Golgi apparatus. Ann Rev Biochem 1987, 56: 63-87.
11. Ulloa-Aguirre, A., Espinoza, R., Damian-Matsumura, P., Chappel, S.C. Immunological and biological potencies of the different molecular species of gonadotrophins. Hum Reprod 1988, 3: 491-501.
12. Jameson, J.L., Becker, C.B., Lindell, C.M., Habener, J.F. Human follicle-stimulating hormone β-subunit gene encodes multiple messenger ribonucleic acid. Mol Endocrinol 1988, 2: 806-15.
13. Hard, K., Mekking, A., Damm, J.B.L. et al. Isolation and structure determination of the intact sialylated N-linked carbohydrate chains of recombinant human follitropin expressed in the Chinese hamster ovary cells. Eur J Biochem 1990, 193: 263-71.
14. Moore, S., Stein, W.M.J. Chromatography of amino acids on polystyrene resins. J Biol Chem 1951, 192: 663-81.
15. Harlin, J., Khan, S.A., Diczfalusy, E. Molecular composition of luteinizing hormone and folliclestimulating hormone in commercial gonadotropin preparations. Fertil Steril 1986, 46: 1055-61.
16. Wide, L. Evidence for diverse structural variations of the forms of human FSH within and between pituitanes. Acta Endocrinol 1987, 115: 7-15.
17. Ulloa-Aguirre, A., Cravioto, A., Damian-Maisumura, P., Jiménez, M., Zambrano, E., Diaz-Sánchez, V. Biological characterization of the naturally occurring analogues of intrapituitary human follicle-stimulating hormone. Hum Reprod 1992, 7: 23-30.
18. Ulloa-Aguirre, A., Damian-Matsumura, P., Jiménez, M., Zambrano, E., Díaz-Sánchez, V. Biological characterization of the isoforms of urinary human follicle-stimulating hormone contained in a purified commercial preparation. Hum Reprod 1992, 7: 1371-8.
19. Nwokoro, N., Chen, H-C., Chrambach, A. Physical, biological, and immunological characterization of highly purified urinary human chorionic gonadotropin components separated by gel electrofocusing. Endocrinology 1981, 108: 291-9.
20. Stanton, P.G., Robertson, D.M., Burgon, P.G., Schmauk-White, B., Hearn, M.T.W. Isolation and physicochemical characterization of human follicle-stimulating hormone isoforms. Endocrinology 1992, 130: 2820-32.
21. Zaidi, A.A., Robertson, D.M., Diczfalusy, E. Studies on the biological and immunological properties of human follitropin: Profiles of two international reference preparations and of an aqueous extract of pituitary glands after electrofocusing. Acta Endocrinol 1981, 97: 157-65.
22. De Boer, W., Mannaerts, B. Recombinant human follicle stimulating hormone. II. Biochemical and biological characteristics. In: From Clone to Clinic. Crommelin, D.J.A., Schellekens, H. (Eds.). Kluwer Academic Publishers: Dordrecht 1990, 253-9.
23. Krasnow, J. Advances in understanding ovarian physiology: Regulation of steroidogenic enzymes in ovarian follicular differentiation. Semin Reprod Endocrinol 1991, 9: 283-302.
24. Heindel, J.J., Treinen, K.A, Physiology of the male reproductive system endocrine, paracrine and autocrine regulation. Toxicol Pathol 1989, 17: 411-45.
25. Mannaerts, B., De Leeuw, R., Geelen, J. et al. Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle-stimulating hormone. Endocrinology 1991, 129: 2623-30.
26. Mannaerts, M.J.L., Kloosterboer, H.J.K., Schuurs, A.H.W.M. Applications of in vitro bioassays for gonadotropins. In: Neuro-Endocrinology of Reproduction. Rolland, R. et al. (Eds.). Elsevier Science Publishers: Amsterdam 1987, 49-58.
27. Overes, H.W.T.M., De Leeuw, R., Kloosterboer, H.J. Regulation of aromatase activity in FSH-primed rat granulosa cells in vitro by folliclestimulating hormone and various amounts of human chorionic gonadotropin. Hum Reprod 1992, 7: 191-6.
28. Odell, W.D., Griffin, J. Pulsatile secretion of chorionic gonadotropin during the normal menstrual cycle. J Clin Endocrinol Metab 1989. 69: 528-32.
29. Wide, L. Les facteurs intrinsèques et extrinsèques qui influencent la stimulation des gonades et la stimulation des gonades et la réceptivité des tissus génitaux féminins formes circulantes des gonadotrophines et leur variabilité. Les gonadotrophines chez l'homme. Contracepit Fertil Sex 1992, 20: 455-62.
30. Stokman, P.G.W., De Leeuw, R., Wijngaard, H.A.G.W., Kloosterboer, H.J., Vemer, H.M., Sanders, A. L. M. Human chorionic gonadotropin in commercial human menopausal gonadotropin preparations. Fertil Steril 1993, 60: 175-8.
31. Mannaerts, B., Uilenbroek, J., Schot, P., De Leeuw, R. Folliculogenesis in hypophysectomized rats after treatment with recombinant human FSH. Biol Reprod 1994, 51: 72-81.
32. Mannaerts, B., De Leeuw, R. Gonadotrophins and follicular growth. In: The Control and Stimulation of Follicular Growth. Shaw, R.W. (Eds.). Adv Reprod Endocrinol 1993, 5: 1-11.
33. Porchet, H.C., Le Cotonnec, J-Y., Canali, S., Zanolo, G. Pharmacokinetics of recombinant human follicle stimulating hormone after intravenous, intramuscular, and subcutaneous administration in monkeys, and comparisons with intravenous administration of urinary follicle stimulating hormone. Drug Metab Dispos 1993, 21: 144-50.
34. Drickamer, K. Clearing up glycoprotein hormones. Cell 1991, 67: 1029-32.
35. Mannaerts, B., Shoham, Z., Schoot, D. et al. Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489) in gonadotropin-deficient volunteers. Fertil Steril 1993, 59: 108-14.
36. Zuidema, J., Pieters, F.A.J.M., Duchateau, G.S.M.J.E. Release and absorption rate aspects in intramuscularly injected pharmaceuticals. Int J Pharm 1988, 47: 1-12.
37. Schoot, D.C., Harlin, J., Shoham, Z. et al. Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women. Hum Reprod 1994, 9: 1237-42.
38. Mannaerts, B., Fauser, B., Lahlou, N. et al. Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadism. Fertil Steril 1996, 65: 406-10.
39. Devroey, P., Van Steirteghem, A., Mannaerts, B., Coelingh Bennink, H. Successfulin-vitro fertilisation and embryo transfer after treatment with recombinant human FSH. Lancet 1992, 339: 1170-1.
40. Devroey, P., Van Steirteghem, A., Mannaerts, B., Coelingh Bennink, H. First singleton term birth after ovarian superovulation with rhFSH. Lancet 1992, 340: 1108-9.
41. Donderwinkel, P.F.J., Schoot, D.C., Coelingh Bennink, H.J.T., Fauser, B.C.J.M. Pregnancy after induction of ovulation with recombinant human FSH in polycystic ovary syndrome. Lancet 1992, 340: 983-4.
42. Van Dessel, H.J.H.M., Donderwinkel, P.F.J., Coelingh Bennink, H.J.T., Fauser, B.C.J.M. First established pregnancy and birth after induction of ovulation with recombinant human follicle-stimulating hormone in polycystic ovary syndrome. Hum Reprod 1994, 9: 55-6.
43. Devroey, P., Mannaerts, B., Smitz. J., Coelingh Bennink, H., Van Steirteghem, A. Clinical outcome of a pilot efficacy study on recombinant human follicle-stimulating hormone (Org 32489) combined with various gonadotrophin-releasing hormone agonist regimens. Hum Reprod 1994, 9: 1064-9.
44. Out, H.J., Mannaerts, B.M.J.L., Driessen, S.G.A.J., Coelingh Bennink, H.J.T. A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum Reprod 1995, 10: 2534-40.
45. Hedon, B., Out, H.J., Hugues, J.N. et al. Efficacy and safety of recombinant FSH (Puregoh®) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilisation: A prospective, randomised, assessor-blind, multicentre trial. Hum Reprod 1995, 10: 3102-6.
46. Out, H.J., Reimitz, P.E., Coelingh Bennink, J.H.T. A prospective, randomized, multicentre study comparing recombinant FSH (Puregon®) either given intramuscularly or subcutaneously in subjects undergoing IVF. Hum Reprod 1995, 10: Abst p. 6.
47. Out, H.J., Driessen, S.G.A.J., Coelingh Bennink, H.J.T. Value of recombinant and urinary FSH (Puregon versus Metrodin) in patients with chronic anovulation. Manuscript in preparation.
48. Kliesch, S., Behre, H.M., Nieschlag, E. High efficacy of gonadotropin or pulsatile GnRH treatment in hypogonadotropic hypogonadal men. Eur J Endocrinol 1994, 131: 347-54.
49. Kliesch, S., Behre, H., Nieschlag, E. Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male. Fertil Steril 1995, 63: 1326-8.